MiNK Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.

About INKT

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. 

CEO
Jennifer S. Buell
CEOJennifer S. Buell
Employees
15
Employees15
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2017
Founded2017
Employees
15
Employees15

INKT Key Statistics

Market cap
41.17M
Market cap41.17M
Price-Earnings ratio
-3.57
Price-Earnings ratio-3.57
Dividend yield
—
Dividend yield—
Average volume
18.74K
Average volume18.74K
High today
$8.60
High today$8.60
Low today
$7.76
Low today$7.76
Open price
$8.32
Open price$8.32
Volume
18.97K
Volume18.97K
52 Week high
$16.93
52 Week high$16.93
52 Week low
$7.76
52 Week low$7.76

Stock Snapshot

With a market cap of 41.17M, MiNK Therapeutics(INKT) trades at $7.98. The stock has a price-to-earnings ratio of -3.57.

On 2026-11-21, MiNK Therapeutics(INKT) stock traded between a low of $7.76 and a high of $8.60. Shares are currently priced at $7.98, which is +2.9% above the low and -7.2% below the high.

MiNK Therapeutics(INKT) shares are trading with a volume of 18.97K, against a daily average of 18.74K.

During the past year, MiNK Therapeutics(INKT) stock moved between $7.76 at its lowest and $16.93 at its peak.

During the past year, MiNK Therapeutics(INKT) stock moved between $7.76 at its lowest and $16.93 at its peak.

INKT News

Simply Wall St 3d
MiNK Therapeutics (Nasdaq:INKT) - Stock Analysis - Simply Wall St

...

MiNK Therapeutics (Nasdaq:INKT) - Stock Analysis - Simply Wall St
TipRanks 7d
MiNK Therapeutics Earnings Call Signals Clinical Momentum

Mink Therapeutics, Inc. ((INKT)) has held its Q3 earnings call. Read on for the main highlights of the call. MiNK Therapeutics delivered a predominantly positi...

People also own

Based on the portfolios of people who own INKT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.